Back to search

Article

Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids

2020-04-01

Abstract excerpt

<title>Abstract</title> <p>Objective To investigate the incidence of tuberculosis (TB) in patients with rheumatic diseases receiving high-dose glucocorticoids and to evaluate the preventive effect of isoniazid (INH). Methods This study included 1618 treatment episodes of prolonged (≥4 weeks), high-dose steroids (≥30mg/day of prednisone) in 1160 patients. Of these, INH was administered in 152 (9.4%) treatment epis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b42fe33a-bf1b-5b26-a484-2d955207c31e
DOI
10.21203/rs.3.rs-19783/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoidsDOI 10.21203/rs.3.rs-19783/v1
Dose-dependent oral glucocorticoid cardiovascular risk in people with immune-mediated inflammatory diseasesSemantic proximity
Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registriesSemantic proximity
Real-World Use of Rituximab in Rheumatoid Arthritis: A 3-Year Analysis from the RBSMR Biologic RegistrySemantic proximity
The impact of TNF inhibitors on glucocorticoid use among patients with inflammatory arthritides: A nationwide cohort studySemantic proximity
Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced HepatotoxicitySemantic proximity
Effectiveness and Safety of Intravenous Golimumab With and Without Concomitant Methotrexate in Patients With Rheumatoid Arthritis in the Prospective, Noninterventional AWARE StudySemantic proximity
Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort studySemantic proximity
Impact of the 2018 Japan Floods on methotrexate and anti-rheumatic drug prescriptions: A longitudinal analysis of the Japanese National DatabaseSemantic proximity
Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infectionSemantic proximity
The Aftermath of Tapering Tocilizumab After Achieving Treatment Target In Patients With Rheumatoid Arthritis: A Nationwide Cohort StudySemantic proximity
Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID eraSemantic proximity
Model-based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosisSemantic proximity
Select a neighboring publication to make it the new centre.